Javad Nazarian

16PUBLICATIONS
193CO-AUTHORS
Gene and molecular therapyBiologically active moleculesMolecular targetsCancer geneticsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 03, 2026
Combinatorial Targeting of Avapritinib-Driven MAP Kinase Activation in High-Grade Glioma.

|May 04, 2026
Triptolide: A Narrative Review of Its Traditional Use, Derivatives, Pharmacology, Antitumor Effect, and Clinical Applications.

|Dec 24, 2025
MTAP-Null Tumors: A Comprehensive Review on Synthetic Vulnerabilities and Therapeutic Strategies.

Bavani Subramaniam, Wai Chin Chong, Aylar Babaei

|May 24, 2025
Transient mRNA CAR T cells targeting GD2 provide dose-adjusted efficacy against diffuse midline glioma and high-grade glioma models.

Jessica B Foster, Peter J Madsen, Kyra Harvey

|May 12, 2025
Decoding the cancer cell proteome: A delicate equilibrium with the genome and epigenome.

Ryan J Duchatel, Javad Nazarian

|Mar 19, 2025
The T cell receptor landscape of childhood brain tumors.

Itay Raphael, Zujian Xiong, Chaim T Sneiderman

Pageof 3

Frequent Collaborators

7 joint publications

Matthew D Dun

5 joint publications

Sabine Mueller

5 joint publications

Carl Koschmann

4 joint publications

Ryan J Duchatel